Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
AstraZeneca
Genmab
Seagen Inc.
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Mayo Clinic
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ohio State University
Mayo Clinic
Hoffmann-La Roche
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Erasca, Inc.
Ipsen
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Washington University School of Medicine
University of Florida
Arvinas Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Genentech, Inc.
OHSU Knight Cancer Institute
University of Oklahoma
St. Jude Children's Research Hospital
MacroGenics
St. Jude Children's Research Hospital
DualityBio Inc.
MacroGenics
Indiana University
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
xCures